We read with great interest the prospective study by Cortejoso et al, 1 which describes the characteristics of pharmaceutical interventions in two geriatric wards (orthogeriatric ward and geriatric day unit) of a general teaching hospital. We strongly agree with their finding that shows the importance of clinical pharmacist involvement in the optimization of pharmacotherapy in elderly patients. Furthermore, we especially appreciate their new and interesting findings that the clinical pharmacist was more frequently requested by physicians and nurses for information about the pharmacotherapy of the patients on the geriatric day unit, compared with the orthogeriatric ward at admission and discharge (5.7% vs 1.2% and 1.7%, respectively, P0.05), and that the pharmacist asked for more confirmation of the physician orders on the geriatric day unit rather than the orthogeriatric ward (19.8% vs 1.8% and 15.7% at admission and discharge, respectively, P0.05). We are from a Joint Commission International (JCI)-accredited academic medical center hospital with 3200 beds in China. Safe medication management and use are pivotal to patient safety and quality of care on which the state-of-the-art standards of the Joint Commission focus. We would like to share our perspectives in the following paragraphs.
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First, the characteristics of the bed turnover of the geriatric day unit and the permanent presence of a clinical pharmacist on the geriatric day unit may be two reasons for explaining the difference in the frequency of pharmaceutical interventions between the two geriatric wards. The study of Cortejoso et al will drive administrators of other hospitals to increase the investment in human resources of clinical pharmacists in geriatric day units. However, the study of Cortejoso et al did not specify the relations between clinical pharmacists in geriatric wards and staff pharmacists in an inpatient pharmacy. Generally, staff pharmacists are responsible for an appropriateness review of physician orders. Is it necessary for the staff pharmacist to re-audit the rationality of orders after the clinical pharmacist in the geriatric day unit completes pharmaceutical care (eg, medication reconciliation, participation in drafting personalized therapeutic 
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Chen and Zhou regimen, medication review, and a planning intervention at admission and discharge)? Is there any difference in the way of checking physician orders by staff pharmacists when they handle orders from the geriatric day unit with the presence of the clinical pharmacist and orders from the orthogeriatric ward without the clinical pharmacist? According to Joint Commission International Accreditation Standards for Hospitals (5th edition), the process to conduct an appropriateness review for an order or prescription prior to dispensing includes evaluation of the following aspects by a trained professional: 1) the appropriateness of the drug, dose, frequency, and route of administration; 2) therapeutic duplication; 3) real or potential allergies or sensitivities; 4) real or potential interactions between the medication and other coadministered medications or food; 5) variation from hospital criteria for use; 6) patient's key information (eg, pregnancy, allergy history, body weight, body surface area, and clinical laboratory test results such as hepatic and renal function, international normalized ratio, blood routine examination, and serum drug concentrations); and 7) other contraindications. 2 For a large hospital with several thousand beds, it seems impractical for several clinical pharmacists to question the appropriateness of physician orders for all inpatients. Therefore, the collaboration among staff pharmacists and clinical pharmacists, as well as their respective role-play, are pivotal to effective, safe, and efficient drug therapy in hospitalized patients and rational allocation of human resources in the medication management and use system. Second, geriatric patients may suffer from multiple chronic diseases and receive more medications compared to younger patients so that they would be more susceptible to drug-drug or drug-disease interactions. 3 Cortejoso et al observed that clinically significant interactions account for the most frequent interventions on the geriatric day unit (21.1%) as well as the orthogeriatric ward at patients' discharge (30.4%). Additionally, omission of a medication in the physician order accounted for 20% of the interventions performed on the orthogeriatric ward at admission and discharge. From these aspects, the study of Cortejoso et al provides good reference for international peers to implement prospective targeted pharmaceutical interventions in elderly inpatients.
Besides the abovementioned requirements on appropriateness review of physician orders, Joint Commission International Accreditation Standards for Hospitals (5th Edition) also requires that the hospital should establish a process to compare the patient's list of medications taken prior to admission against the initial orders. 2 We successfully improved the appropriateness of physician orders for oral medications in geriatric VIP patients during the journey to JCI accreditation by a pharmacist-led multidisciplinary intervention program, with the proportion of drug-related problems decreasing significantly from 13.0% (before JCI accreditation) to 3.5% (after JCI accreditation) (P0.01). 3 Combining the valuable findings of Cortejoso et al and JCI accreditation standards on medication use, we believe that the pharmacist-led multidisciplinary team can do a lot for geriatric patients, toward the effective, safe, and sustained use of medicines.
